Cirrhosis Patients Experiencing ARDS Encounter Significant Challenges
By
Debbie Bunch
April 20, 2026
Clinical Scorecard: Cirrhosis Patients Experiencing ARDS Encounter Significant Challenges
At a Glance
Category Detail
Condition Acute Respiratory Distress Syndrome (ARDS) in patients with cirrhosis
Key Mechanisms Development of ARDS secondary to cirrhosis complications such as pneumonia, gastrointestinal bleeding, and sepsis.
Target Population Patients with cirrhosis admitted to the ICU
Care Setting Intensive Care Unit (ICU)
Key Highlights
26.6% of cirrhosis patients in ICU developed ARDS. 28-day mortality rate for these patients is 75.2%. Severity of liver disease (MELD score) and hypoxemia (PaO₂/FiO₂ ratio) are key mortality risk factors. Patients admitted for acute respiratory failure have better outcomes than those with non-respiratory complications. Systematic screening for ARDS in cirrhosis patients could improve early treatment.
Guideline-Based Recommendations
Diagnosis
Systematic screening for ARDS in cirrhosis patients.
Management
Utilize lung-protective ventilation strategies for ARDS management.
Monitoring & Follow-up
Assess severity of liver disease using MELD score and monitor PaO₂/FiO₂ ratio.
Risks
High mortality rates associated with ARDS in cirrhosis patients.
Patient & Prescribing Data
Cirrhosis patients requiring ICU admission, particularly those with ARDS.
Early identification and management of ARDS can potentially improve outcomes.
Clinical Best Practices
Refine prognostic assessment based on reason for ICU admission. Encourage early liver transplantation evaluation for high-risk patients.
References